Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CVRX CVRx	$7.03 -2.9%	$6.98	$4.30 ▼ $18.55	$189.34M	1.27	314,140 shs	232,606 shs
INGN Inogen	$7.46 -2.7%	$6.80	$5.70 ▼ $13.33	$207.40M	1.72	284,956 shs	182,241 shs
MGRM Monogram Orthopaedics	$5.33 -0.4%	$4.24	$1.92 ▼ $6.02	$190.93M	0.69	209,812 shs	82,175 shs
PYPD PolyPid	$3.45 +0.6%	$3.50	$2.30 ▼ $3.93	$54.53M	1.4	79,908 shs	62,483 shs

The 10 Best AI Stocks to Own in 2025

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CVRX CVRx	-2.90%	-2.90%	-16.80%	+10.88%	-11.79%
INGN Inogen	-2.74%	+15.12%	+14.07%	+22.50%	-38.75%
MGRM Monogram Orthopaedics	-0.37%	-1.30%	-9.81%	+105.79%	+97.41%
PYPD PolyPid	+0.58%	+7.14%	-8.49%	+25.91%	-1.15%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CVRX CVRx	2.8219 of 5 stars	3.4	1.0	0.0	2.4	4.2	0.6
INGN Inogen	4.3812 of 5 stars	3.3	5.0	3.9	2.7	1.7	0.6
MGRM Monogram Orthopaedics	2.0667 of 5 stars	1.8	5.0	0.0	3.3	1.7	0.6
PYPD PolyPid	3.0134 of 5 stars	3.6	5.0	0.0	2.4	1.7	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CVRX CVRx	2.86	Moderate Buy	$14.00	99.15% Upside
INGN Inogen	2.50	Moderate Buy	$11.00	47.45% Upside
MGRM Monogram Orthopaedics	3.50	Strong Buy	$5.40	1.31% Upside
PYPD PolyPid	3.17	Buy	$12.40	259.42% Upside

Current Analyst Ratings Breakdown

Latest PYPD, CVRX, INGN, and MGRM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/14/2025	PYPD PolyPid	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$15.00 ➝ $13.00
8/14/2025	PYPD PolyPid	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
8/13/2025	PYPD PolyPid	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$13.00
8/5/2025	CVRX CVRx	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$11.00
7/7/2025	CVRX CVRx	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
6/18/2025	PYPD PolyPid	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$12.00 ➝ $9.00
6/17/2025	PYPD PolyPid	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Outperform ➝ Market Outperform	$16.00 ➝ $14.00
6/16/2025	INGN Inogen	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$14.00
6/15/2025	INGN Inogen	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$14.00
6/9/2025	PYPD PolyPid	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$11.00 ➝ $13.00
6/5/2025	PYPD PolyPid	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$9.00

(Data available from 8/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CVRX CVRx	$51.29M	3.58	N/A	N/A	$2.22 per share	3.17
INGN Inogen	$335.70M	0.60	N/A	N/A	$7.38 per share	1.01
MGRM Monogram Orthopaedics	$370K	514.13	N/A	N/A	$0.42 per share	12.69
PYPD PolyPid	N/A	N/A	N/A	N/A	$1.29 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CVRX CVRx	-$59.97M	-$2.10	N/A	N/A	N/A	-95.61%	-79.31%	-40.96%	11/4/2025 (Estimated)
INGN Inogen	-$35.89M	-$1.06	N/A	N/A	N/A	-7.58%	-13.77%	-8.52%	N/A
MGRM Monogram Orthopaedics	-$16.33M	-$0.45	N/A	N/A	N/A	N/A	-115.71%	-92.75%	N/A
PYPD PolyPid	-$29.02M	-$4.30	N/A	∞	N/A	N/A	-453.95%	-138.92%	N/A

Latest PYPD, CVRX, INGN, and MGRM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2025	Q2 2025	MGRM Monogram Orthopaedics	-$0.11	-$0.16	-$0.05	-$0.16	N/A	N/A
8/13/2025	Q2 2025	PYPD PolyPid	-$0.53	-$0.78	-$0.25	-$0.78	N/A	N/A
8/7/2025	Q2 2025	INGN Inogen	-$0.22	-$0.15	+$0.07	-$0.15	$90.40 million	$92.28 million
8/4/2025	Q2 2025	CVRX CVRx	-$0.52	-$0.57	-$0.05	-$0.57	$13.22 million	$13.59 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CVRX CVRx	N/A	N/A	N/A	N/A	N/A
INGN Inogen	N/A	N/A	N/A	N/A	N/A
MGRM Monogram Orthopaedics	N/A	N/A	N/A	N/A	N/A
PYPD PolyPid	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CVRX CVRx	0.85	11.99	10.78
INGN Inogen	N/A	3.03	2.67
MGRM Monogram Orthopaedics	N/A	7.00	7.00
PYPD PolyPid	N/A	2.28	0.71

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CVRX CVRx	75.27%
INGN Inogen	89.94%
MGRM Monogram Orthopaedics	0.45%
PYPD PolyPid	26.47%

Insider Ownership

Company	Insider Ownership
CVRX CVRx	13.90%
INGN Inogen	1.46%
MGRM Monogram Orthopaedics	28.10%
PYPD PolyPid	24.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CVRX CVRx	160	26.15 million	22.52 million	Optionable
INGN Inogen	1,030	27.04 million	26.65 million	Optionable
MGRM Monogram Orthopaedics	28	35.69 million	25.66 million	Not Optionable
PYPD PolyPid	80	15.90 million	11.97 million	No Data

PYPD, CVRX, INGN, and MGRM Headlines

Recent News About These Companies

PolyPid (NASDAQ:PYPD) Given "Buy" Rating at HC Wainwright

August 15 at 2:29 PM | marketbeat.com

PolyPid's (PYPD) "Buy" Rating Reaffirmed at HC Wainwright

August 15 at 2:51 AM | americanbankingnews.com

PolyPid price target raised to $10 from $9 at Roth Capital

August 14 at 6:21 PM | msn.com

PolyPid Releases Mid-2025 Financial Update

August 14 at 6:21 PM | theglobeandmail.com

PolyPid Reports Strong Phase 3 Results and Financial Update

August 14 at 10:27 AM | msn.com

PolyPid Ltd. (NASDAQ:PYPD) Q2 2025 Earnings Call Transcript

August 14 at 10:27 AM | msn.com

PolyPid Ltd (PYPD) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Rising Expenses

August 14 at 10:27 AM | finance.yahoo.com

PolyPid Ltd. (PYPD) Q2 2025 Earnings Call Transcript

August 13 at 5:04 PM | seekingalpha.com

PolyPid sees cash runway ‘well into’ 2026

August 13 at 2:01 PM | msn.com

PolyPid Reports Positive Phase 3 Results and Strengthens Leadership

August 13 at 8:17 AM | tipranks.com

PolyPid Provides Corporate Update and Reports Second Quarter 2025 Financial Results

August 13 at 7:30 AM | globenewswire.com

PolyPid Ltd.: PolyPid Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer

August 12, 2025 | finanznachrichten.de

PolyPid appoints Tweezer-Zaks as Chief Medical Officer

August 12, 2025 | msn.com

PolyPid Appoints New Chief Medical Officer Amid Strategic Advancements

August 12, 2025 | msn.com

PolyPid Ltd. Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer

August 12, 2025 | quiverquant.comQ

PolyPid Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer

August 12, 2025 | globenewswire.com

PolyPid Ltd. (NASDAQ:PYPD) Given Average Rating of "Buy" by Brokerages

August 6, 2025 | americanbankingnews.com

PolyPid to Report Second Quarter 2025 Financial Results and Operational Highlights on August 13, 2025

July 30, 2025 | globenewswire.com

PYPD: Positive Topline Data From D-PLEX₁₀₀ Trial Contributes to Multiple Subsequent Benefits

July 16, 2025 | finance.yahoo.com

PolyPid Unveils a Long-Acting GLP-1 Receptor Agonists Delivery Platform Targeting the Diabetes and Weight Loss Market

July 15, 2025 | finance.yahoo.com

PolyPid Launches Long-Acting GLP-1 Delivery Platform for Diabetes Market

July 15, 2025 | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

PYPD, CVRX, INGN, and MGRM Company Descriptions

CVRx NASDAQ:CVRX

$7.03 -0.21 (-2.90%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$7.04 +0.01 (+0.14%)

As of 08/15/2025 07:46 PM Eastern

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Inogen NASDAQ:INGN

$7.46 -0.21 (-2.74%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$7.45 -0.01 (-0.13%)

As of 08/15/2025 04:10 PM Eastern

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Monogram Orthopaedics NASDAQ:MGRM

$5.33 -0.02 (-0.37%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$5.34 +0.00 (+0.09%)

As of 08/15/2025 04:35 PM Eastern

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas.

PolyPid NASDAQ:PYPD

$3.45 +0.02 (+0.58%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$3.44 -0.02 (-0.43%)

As of 08/15/2025 04:10 PM Eastern

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time